Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use

Journal of the American Board of Family Medicine - United States
doi 10.3122/jabfm.2020.01.190143
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Board of Family Medicine (ABFM)

Related search

The Effect of Hydroxyurea in Sickle Cell Disease Patients

IOSR Journal of Dental and Medical Sciences
2017English

Hydroxyurea in Sickle Cell Disease: Our Experience in Western India

Indian Journal of Hematology and Blood Transfusion
Hematology
2015English

Adhesion Molecules and Hydroxyurea in the Pathophysiology of Sickle Cell Disease

Haematologica
Hematology
2008English

Effect of Hydroxyurea on Priapism in Men With Sickle Cell Disease

West Indian Medical Journal
Medicine
2016English

Neutrophils Remain Detrimentally Active in Hydroxyurea-Treated Patients With Sickle Cell Disease

PLoS ONE
Multidisciplinary
2019English

Preliminary Report of a Toxicity Study of Hydroxyurea in Sickle Cell Disease

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1999English

Practical Management of Sickle Cell Disease.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Pediatric to Adult Care Co-Location Transitional Model for Youth With Sickle Cell Disease

American Journal of Hematology
Hematology
2017English

Mortality in Sickle Cell Patients on Hydroxyurea Therapy

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy